Table 3. LOH status, mutation results and clinicopathological features of primary breast tumours.

	Clinicopathology						LOH			Mutations or SNPs
Case	Histo	Stage	Grade	D8S137	D8S1048	Spanning exon	nta	Codon	Base change	a.a change
1	Ductal	IIIA	1	LOH	NI	5	25199	IVS5+15	A→G	Intronic
2	Lobular	IIIA	2	NL	CR
3	NS	IIB	3	CR	LOH
4	Med/duct	IIB	3	NI	CR	5	25199	IVS5+15	A→G	Intronic
5	Ductal	IIIB	2	NI	NI
6	Ductal	IIIB	2	NI	NI
7	Ductal	NS	2	NI	NL	5	25199	IVS5+15	A→G	Intronic
8	Ductal	IIB	NS	LOH	NI
9	Ductal	IIA	2	LOH	NI
10	Ductal	IIB	3	NL	NL	5	25199	IVS5+15	A→G	Intronic
11	NS	IIB	1	NL	NL	5	25199	IVS5+15	A→G	Intronic
12	Lob/duct	NS	2	NI	NI
13	Ductal	IIIA	3	LOH	NL	5	25199	IVS5+15	A→G	Intronic
14	Ductal	IIA	2	NL	NL
15	Ductal	IIB	3	NL	NL	5	25199	IVS5+15	A→G	Intronic
16	Ductal	IIA	2	NI	NI	5	25199	IVS5+15	A→G	Intronic
17	Ductal	IIA	3	NL	NL	5	25199	IVS5+15	A→G	Intronic
18	Ductal	NS	NS	NI	NL
19	Ductal	NS	NS	NI	LOH	5	25199	IVS5+15	A→G	Intronic
20	Ductal	NS	NS	CR	NL
21	Ductal	IIA	2	CR	CR	5	25199	IVS5+15	A→G	Intronic
22	Ductal	NS	3	NI	NL
23	Ductal	IIA	3	NI	NI	5	25199	IVS5+15	A→G	Intronic
24	Ductal	IIIB	2	NL	CR	5	25199	IVS5+15	A→G	Intronic
25	Ductal	IIA	2	NL	NL

^aBases counted from ATG start codon; NS=not specified; NL=no loss; LOH=loss of heterozygosity; NI=not informative; CR=can't read; ND=not done.